Long-term effect of Helicobacter pylori infection on serum pepsinogens

被引:22
作者
Kikuchi, S
Kurosawa, M
Sakiyama, T
Tenjin, H
Miki, K
Wada, O
Inaba, Y
机构
[1] Juntendo Univ, Sch Med, Dept Epidemiol & Environm Hlth, Bunkyo Ku, Tokyo 1138421, Japan
[2] Clin Attached Kanto Shin Etsu Reg Taxat Bur, Chiyoda Ku, Tokyo 1020074, Japan
[3] Univ Tokyo, Fac Med, Dept Hyg & Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan
[4] Univ Tokyo, Fac Med, Dept Internal Med 1, Bunkyo Ku, Tokyo 1138655, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 2000年 / 91卷 / 05期
关键词
long-term effect; Helicobacter pylori; serum pepsinogens; inflammation atrophy of gastric mucosa;
D O I
10.1111/j.1349-7006.2000.tb00969.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Serum pepsinogen values are markers of gastric mucosal status and of gastric cancer risk. The effect of Helicobacter pylori infection and sibship size on change of serum pepsinogen values over a seven-year span was investigated. Data from 2584 subjects with phlebotomy were analyzed both in 1989 and in 1996. The subjects were classified by H. pylori serology and sibship size (1-3 vs. 4 and more). Pepsinogen I (PG I) to II (PG II) ratio in '96 minus that in '89 was defined as Delta PG I/II and compared among the groups, Delta PG I/II was lower and decrease of PG I/II was more frequent among H. pylori-positive subjects than among negative subjects. The difference was owing to a decrease of PG I in all subjects and owing to an increase of PG II in those not younger than 30 years in '89, In H, pylori-positive subjects, those with a larger sibship size showed lower Delta PG I/II and higher frequency of PG I/II decline. H. pylori infection exerts a reducing effect on PG I/II during the seven-year span. The effect of H. pylori is stronger among those with a larger sibship size, who are expected to have been infected with H, pylori in childhood. Inducing atrophy of gastric mucosa, which is reflected by a decline of PG I/II, may be one of the mechanisms through which H. pylori elevates the risk of gastric cancer.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 23 条
[1]  
Asaka M, 1996, Helicobacter, V1, P52, DOI 10.1111/j.1523-5378.1996.tb00008.x
[2]   RELATIONSHIP OF HELICOBACTER-PYLORI TO SERUM PEPSINOGENS IN AN ASYMPTOMATIC JAPANESE POPULATION [J].
ASAKA, M ;
KIMURA, T ;
KUDO, M ;
TAKEDA, H ;
MITANI, S ;
MIYAZAKI, T ;
MIKI, K ;
GRAHAM, DY .
GASTROENTEROLOGY, 1992, 102 (03) :760-766
[3]  
BLASER MJ, 1995, CANCER RES, V55, P562
[4]   ASSOCIATION BETWEEN INFECTION WITH HELICOBACTER-PYLORI AND RISK OF GASTRIC-CANCER - EVIDENCE FROM A PROSPECTIVE INVESTIGATION [J].
FORMAN, D ;
NEWELL, DG ;
FULLERTON, F ;
YARNELL, JWG ;
STACEY, AR ;
WALD, N ;
SITAS, F .
BRITISH MEDICAL JOURNAL, 1991, 302 (6788) :1302-1305
[5]   SERUM PEPSINOGENS AS MARKERS OF RESPONSE TO THERAPY FOR HELICOBACTER-PYLORI GASTRITIS [J].
HUNTER, FM ;
CORREA, P ;
FONTHAM, E ;
RUIZ, B ;
SOBHAN, M ;
SAMLOFF, IM .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (11) :2081-2086
[6]  
KIKUCHI S, 1994, CANCER, V73, P2695, DOI 10.1002/1097-0142(19940601)73:11<2695::AID-CNCR2820731108>3.0.CO
[7]  
2-O
[8]  
KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO
[9]  
2-4
[10]   Helicobacter pylori risk associated with sibship size and family history of gastric diseases in Japanese adults [J].
Kikuchi, S ;
Kurosawa, M ;
Sakiyama, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (11) :1109-1112